These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 1718690)

  • 1. Protective effects of calcium antagonists against ischaemia and reperfusion damage.
    Ferrari R; Visioli O
    Drugs; 1991; 42 Suppl 1():14-26; discussion 26-7. PubMed ID: 1718690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of calcium antagonists in the treatment of myocardial ischemia.
    Follath F
    Am Heart J; 1989 Nov; 118(5 Pt 2):1093-6; discussion 1096-7. PubMed ID: 2683702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcium antagonists and myocardial infarction.
    Hansen JF
    Cardiovasc Drugs Ther; 1991 Aug; 5(4):665-70. PubMed ID: 1888690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcium antagonists during and after myocardial infarction.
    Sleight P
    Drugs; 1996 Feb; 51(2):216-25. PubMed ID: 8808164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcium antagonists for acute ischemic heart disease.
    Winniford MD; Willerson JT; Hillis LD
    Am J Cardiol; 1985 Jan; 55(3):116B-124B. PubMed ID: 3881904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of reperfusion damage in working rat hearts by calcium antagonists and calmodulin antagonists.
    Higgins AJ; Blackburn KJ
    J Mol Cell Cardiol; 1984 May; 16(5):427-38. PubMed ID: 6737483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The haemodynamic effects of nifedipine, verapamil and diltiazem in patients with coronary artery disease. A review.
    Soward AL; Vanhaleweyk GL; Serruys PW
    Drugs; 1986 Jul; 32(1):66-101. PubMed ID: 2874975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcium channel antagonists. Part II: Use and comparative properties of the three prototypical calcium antagonists in ischemic heart disease, including recommendations based on an analysis of 41 trials.
    Opie LH
    Cardiovasc Drugs Ther; 1988 Jan; 1(5):461-91. PubMed ID: 3154677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myocardial protection with calcium-channel blockers during ischaemia and reperfusion by PTCA.
    Chouairi S; Carrie D; Puel J
    Eur Heart J; 1995 Aug; 16 Suppl H():3-8. PubMed ID: 8846802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secondary and tertiary prevention with calcium antagonists in coronary artery disease.
    Burkart F
    Drugs; 1992; 43 Suppl 1():37-42. PubMed ID: 1378787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are calcium antagonists cardioprotective?
    Kendall MJ; Horton RC
    J R Coll Physicians Lond; 1985 Apr; 19(2):85-9. PubMed ID: 3889321
    [No Abstract]   [Full Text] [Related]  

  • 12. The role of calcium antagonists in ischaemic heart disease.
    Pepine CJ
    Eur Heart J; 1995 Aug; 16 Suppl H():19-24. PubMed ID: 8846801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Review of calcium antagonist trials in acute myocardial infarction.
    Roberts R
    Clin Cardiol; 1989 Jul; 12(7 Suppl 3):III41-7. PubMed ID: 2691141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Myocardial cellular mechanism of action of calcium antagonists].
    Ferrari R; Boffa GM; Ciampalini G; Ceconi C
    Cardiologia; 1985 Feb; 30(2):77-89. PubMed ID: 3905004
    [No Abstract]   [Full Text] [Related]  

  • 15. [Calcium channel antagonists and myocardial ischemia or ischemia/reperfusion].
    Lièvre M; Boissel JP
    Arch Mal Coeur Vaiss; 1993 Jul; 86 Spec No 4():91-8. PubMed ID: 8304818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dissociation of cardiodepression from cardioprotection with calcium antagonists: diltiazem protects ischemic rat myocardium with a lower functional cost as compared with verapamil or nifedipine.
    Grover GJ; Sleph PG
    J Cardiovasc Pharmacol; 1989 Aug; 14(2):331-40. PubMed ID: 2476610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcium-channel blocking agents.
    Leonard RG; Talbert RL
    Clin Pharm; 1982; 1(1):17-33. PubMed ID: 6764159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term effects of diltiazem and verapamil on mortality and cardiac events in non-Q-wave acute myocardial infarction without pulmonary congestion: post hoc subset analysis of the multicenter diltiazem postinfarction trial and the second danish verapamil infarction trial studies.
    Gibson RS; Hansen JF; Messerli F; Schechtman KB; Boden WE
    Am J Cardiol; 2000 Aug; 86(3):275-9. PubMed ID: 10922432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diltiazem in acute myocardial infarction treated with thrombolytic agents: a randomised placebo-controlled trial. Incomplete Infarction Trial of European Research Collaborators Evaluating Prognosis post-Thrombolysis (INTERCEPT).
    Boden WE; van Gilst WH; Scheldewaert RG; Starkey IR; Carlier MF; Julian DG; Whitehead A; Bertrand ME; Col JJ; Pedersen OL; Lie KI; Santoni JP; Fox KM
    Lancet; 2000 May; 355(9217):1751-6. PubMed ID: 10832825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Verapamil: a review of its pharmacological properties and therapeutic use in coronary artery disease.
    Brogden RN; Benfield P
    Drugs; 1996 May; 51(5):792-819. PubMed ID: 8861548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.